A Win For Madrigal Pharmaceuticals, Inc.
Mon, Dec 19, 2022 at 07:02 PM
Madrigal Pharmaceuticals, Inc. (MDGL:NASDAQ) shot up at $234.83, representing a gain of 268.1%. On Mon, Dec 19, 2022, MDGL:NASDAQ hit a New 2-Week High of $234.83. The stock appeared on our News Catalysts scanner on Mon, Dec 19, 2022 at 04:45 PM in the 'MISCELLANEOUS' category. From Mon, Dec 05, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days
About Madrigal Pharmaceuticals, Inc. (MDGL:NASDAQ)
Madrigal Pharmaceuticals Inc is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH).
Top 10 Gainers:
- Starry Group Holdings Inc. Class A (STRY:NYSE), 581.82%
- Madrigal Pharmaceuticals, Inc. (MDGL:NASDAQ), 268.07%
- Axcella Health Inc. (AXLA:NASDAQ), 165.27%
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- Soleno Therapeutics, Inc. (SLNO:NASDAQ), 103.86%
- Qumu Corporation (QUMU:NASDAQ), 100%
- Viking Therapeutics, Inc. (VKTX:NASDAQ), 73.88%
- Camber Energy, Inc. (CEI:NYSEMKT), 72.9%
- Landos Biopharma Inc. (LABP:NASDAQ), 56.31%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 49.26%